💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

FTC not sold on Walgreens' plan to win nod for Rite Aid deal: Bloomberg

Published 01/20/2017, 12:23 PM
Updated 01/20/2017, 12:31 PM
© Reuters.  FTC not sold on Walgreens' plan to win nod for Rite Aid deal: Bloomberg
WBA
-
FREDQ
-
US90274J5618=UBSS
-

(Reuters) - The U.S. Federal Trade Commission is not satisfied with Walgreens Boots Alliance Inc's (O:WBA) plan to divest stores to win antitrust clearance for its acquisition of Rite Aid Corp (N:RAD), Bloomberg reported, citing people familiar with the matter.

The FTC isn't convinced that Walgreen's proposal to sell 865 drugstores to Fred's Inc (O:FRED) would do enough to preserve competition that would be lost in the $9.4 billion tie-up, Bloomberg reported on Friday. (http://bloom.bg/2iJXpwf)

The FTC is also unlikely to complete its review of the deal before the deadline of Jan. 27 to close the transaction, Bloomberg reported.

Walgreens will have to pay Rite Aid a termination fee of $325 million if the FTC blocks the deal.

Walgreens declined to comment. Rite Aid, Fred's and the FTC could not be immediately reached for comment.

Walgreens shares were down 2 percent in heavy trading. Rite Aid shares tumbled about 14 percent and Fred's shares fell 5.8 percent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.